Wendy Berg presented 2 papers with the early results of the ACRIN 6666 trial
When added to mammography in the high risk setting, the diagnostic sensitivity of screening increases. The second paper showed the serious downside with a large proportion of false positive screens with additional unnecessary biopsies.
Increased workload/demand for breast MRI as a result of the 2007 American Cancer Society guidelines on screening high risk women, similar to the October 2006 UK NICE guidelines
It was shown that in the USA, current units could theoretically cope with the increased numbers of screening examinations 2-3 per week, without additional investment.
